Benzinga·2025-11-13 17:03Company Performance - JD.com reported a quarterly revenue growth of 14.9% year-over-year to $42.01 billion, surpassing the analyst consensus estimate of $41.33 billion [2] - JD posted an adjusted net income per ADS of 52 cents, exceeding the analyst consensus estimate of 34 cents [2] Stock Movements - Mersana Therapeutics Inc shares surged 205% to $27.06 after announcing its acquisition by Day One Biopharmaceuticals [8] - Nuvve Holding Corp shares increased 215% to $0.4916 following an aggregation agreement in Japan [8] - Ondas Holdings Inc shares rose 24% to $6.82 after reporting better-than-expected third-quarter results and raising its FY25 sales guidance [8] - Korro Bio Inc shares dropped 79% to $6.48 after announcing a wind-down of research and development activities [8] - Applied Therapeutics Inc shares fell 44% to $0.5070 following third-quarter results [8] - EPWK Holdings Ltd shares decreased 33% to $0.0434 after announcing a 40-for-1 share consolidation effective November 17 [8]